Adult Arterial HTN
5 mg daily in the morning. May be increased to 10 mg daily in single dose after 1 mth of treatment. CHF
Initially 2.5 mg daily in the morning. May be increased up to 5 mg daily once BP acceptability has been demonstrated. Prevention of stroke recurrence in patients w/ history of cerebrovascular disease
2.5 mg daily for 2 wk, then increase to 5 mg daily for another 2 wk before introducing indapamide. Treatment initiation: Any time from 2 wk up to several yr after initial stroke episode. Risk reduction of CV event in patients w/ stable CAD
5 mg once daily for 2 wk, then increased up to 10 mg once daily. Elderly Arterial HTN
Initially 2.5 mg daily in the morning. May be increased to 5 mg daily after 1 mth of treatment. Risk reduction of CV event
2.5 mg once daily for 1 wk, then 5 mg once daily the next wk before increasing to 10 mg once daily.